Benfotiamine

Description

benfotiamine , a lipid-soluble from of vitamin B1, was developed in Japan in the late ***0`s, it&#**9;s has been in widespread use in Japan since ***2 and in Europe since ***2 with encouraging results . benfotiamine was used to treat alcoholic neuropathy , sciatica can also block damage by hyperglycemia . it can prevent toe prevent and end the ravage of diabetic neuropathy . it is effective in the treatment of diabetic polyneuropathy and can also act as a new approach to stopping and preventing diabetic retinopathy . apart from the above , benfotiamine also delays the formation of advanced glycosylation end-products and inhibits formation of advanced glycation end products. moreover , benfotiamine is indicated in end-stage renal disease, which suggests that diabetic nephropathy can be prevented and alleviated. benfotiamine is different from vitamin B1. it can be absorbed by the body better than thiamine itself , and levels of thiamine remain higher for longer , thiamine absorption from benfotiamine is about five times greater than from conventional thiamine supplements , the effect is even more impressive at the tissue level , hence , benfotiamine is much more effective than itself and other lipid forms of thiamine , in the meanwhile , benfotiamine is actually less toxic than conventional thiamine supplements , and suitable , and suitable for the big-dosage benfotiamine , a lipid-soluble from of vitamin B1, was developed in Japan in the late ***0`s, it&#**9;s has been in widespread use in Japan since ***2 and in Europe since ***2 with encouraging results . benfotiamine was used to treat alcoholic neuropathy , sciatica can also block damage by hyperglycemia . it can prevent toe prevent and end the ravage of diabetic neuropathy . it is effective in the treatment of diabetic polyneuropathy and can also act as a new approach to stopping and preventing diabetic retinopathy . apart from the above , benfotiamine also delays the formation of advanced glycosylation end-products and inhibits formation of advanced glycation end products. moreover , benfotiamine is indicated in end-stage renal disease, which suggests that diabetic nephropathy can be prevented and alleviated. benfotiamine is different from vitamin B1. it can be absorbed by the body better than thiamine itself , and levels of thiamine remain higher for longer , thiamine absorption from benfotiamine is about five times greater than from conventional thiamine supplements , the effect is even more impressive at the tissue level , hence , benfotiamine is much more effective than itself and other lipid forms of thiamine , in the meanwhile , benfotiamine is actually less toxic than conventional thiamine supplements , and suitable , and suitable for the big-dosage